SP-624 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-07-15 in 23d
ESTIMATED |
READOUT
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Maj
Phase 2 · Major Depressive Disorder |
Sirtsei Pharmaceuticals, Inc. | SP-624 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|